COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Crohn's Disease Endoscopic REmission Definition in an Objective Way (CREDO1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03498625
Recruitment Status : Recruiting
First Posted : April 17, 2018
Last Update Posted : April 11, 2019
Gilead Sciences
Roche Pharma AG
Information provided by (Responsible Party):
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 13, 2020
Estimated Study Completion Date : March 13, 2020